Navigation Links
Monogram Announces 2008 Second Quarter Financial Results
Date:7/29/2008

urrent portion of loans payable and

capital lease obligations 10,175 4,469

Contingent value rights 2,060 2,119

Total current liabilities 25,447 17,061

Long-term 3% convertible promissory

note 19,678 20,786

Long-term 0% convertible promissory

note 14,817 18,511

Long-term portion of restructuring

costs - 289

Long-term deferred revenue 20,248 13,622

Other long-term liabilities 661 282

Total liabilities 80,851 70,551

Stockholders' deficit:

Common stock 135 134

Additional paid-in capital 289,243 286,196

Accumulated other comprehensive loss (3) (31)

Accumulated deficit (294,785) (287,539)

Total stockholders' deficit (5,410) (1,240)

Total liabilities and

stockholders' deficit $75,441 $69,311

(1) The balance sheet data at December 31, 2007 is derived from audited financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2007 filed with the Securities and Exchange Commission.

contacts: Alfred G. Merriweather Jeremiah Hall

Chief Financial Officer Feinstein Kean Healthcare

Tel: 650 624 4576 Tel: 415 677 2700

amerriweather@ jeremiah.hall@

monogrambio.com fkhealth.com


'/>"/>
SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
5. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... cooperation with the Greater VA Healthcare System in West Los Angeles, ... expected to soar to more than 5,000 veterans, active military personnel ... ... 6, 2009 -- Volunteer organizations and members of the community, in ... will once again create a holiday party. This year,s attendance is ...
(Date:12/5/2009)... CAPE TOWN, South Africa, December 5 The ... outskirts of Cape Town opened its doors,today (5 ... joined by,Western Cape Premier Helen Zille, 2010 FIFA ... Jordaan, South African Football Association,President Kirsten Nematandani and ...
(Date:12/5/2009)... Technology Center helps companies develop and test their cleaning processes. The ... variety of industries and solve problems for customers relating to cleaning ... ... 5, 2009 -- Midbrook, Inc , a Jackson, MI-based company, ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... have identified a subgroup of hard-to-treat breast cancers that ... in the treatment of breast tumors. They also have ... help identify patients most likely to benefit from cisplatin ... trial anticipated to begin at the MGH Gillette Center ...
... a dermatologist has a higher survival rate than by a ... to detect// the tumor in its early stages which can ... ,Individuals whose melanoma is diagnosed by a dermatologist may be ... years than those with melanoma diagnosed by a non-dermatologist, according ...
... from the researchers from Yale School of Medicine and ... first time found evidence of a// molecular mechanism that ... ,This discovery may help the development of ... and for cognitive changes in schizophrenia, bipolar disorder, or ...
... a Mediterranean country, is considered notoriously image-conscious. It may be ... clashing fiercely all the time. ,But the thirst ... ,Only that should explain why the Fist National Bank has ... ,Its website dubs the 'plastic surgery loans' as ...
... have found that the use of remote monitoring ... potential to significantly// improve clinical outcomes (mortality, morbidity ... remote monitoring (telephone support or telemonitoring) to electronically ... pressure, weight and ECG and oxygen details, to ...
... An initiative focused on motivating seniors and others with Medicare ... off by the U.S. Department of Health and Human Services ... The campaign is titled: A Healthier US Starts Here. ... the spring and summer, the Medicare Prevention tour bus will ...
Other Medicine News:Health News:Researchers Have Identified Subgroup Sensitive to the Drug Cisplatin 2Health News:Chances of Survival for Melanoma is High When Detected by Dermatologists 2Health News:New Light on Working of Brain Networks 2Health News:New Light on Working of Brain Networks 3Health News:Loans for Cosmetic Surgery in Lebanon 2Health News:Research Uncovers the Significant Benefits of Remote Monitoring 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2
(Date:12/4/2009)... Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) ... of schizophrenia and manic or mixed episodes associated with ... ,, The updated Zyprexa label states that clinicians ... gain and hyperlipidemia in adolescents compared to adults and ...
(Date:12/4/2009)... (Pink Sheets: VRMLQ) announced that on December 3, 2009, it ... Disclosure Statement with the United States Bankruptcy Court for the ... the adequacy of the Disclosure Statement is presently scheduled for ... the Plan scheduled for January 7, 2010. ,, "We are ...
(Date:12/4/2009)... Dec. 4 Amber Pharmacy announced today that it ... Inc. (ACHC) for specialized pharmacy services. For nearly 15 ... and services to meet the unique needs of specialized ... of services to transplant programs. They work with over ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 1STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 2STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 3STEMCELL Technologies Inc Announces Direct Distribution to Spain 59120 4Purity Products Releases Their Brand New Mediterranean Diet Resveratrol Formula 59118 1Purity Products Releases Their Brand New Mediterranean Diet Resveratrol Formula 59118 2Chronic Fatigue Syndrome and Stem Cell Therapy Latest Research Available at CheneyResearch com 59116 1Chronic Fatigue Syndrome and Stem Cell Therapy Latest Research Available at CheneyResearch com 59116 2Chronic Fatigue Syndrome and Stem Cell Therapy Latest Research Available at CheneyResearch com 59116 3
... AACR Meeting Highlights Potential Therapeutic Approach to Treat ... Micromet, Inc. (Nasdaq: MITI ), ... the treatment of cancer, inflammation and autoimmune diseases, ... of the American Association for Cancer Research (AACR). ...
... for Cancer Research -PRINCETON, N.J., April 21 ... announced preclinical efficacy and safety data from multiple ... cancer targets (CXCR4, fucosyl-GM1, glypican-3, mesothelin, CD70) and ... Data from the studies were presented at the ...
Other Medicine Technology:Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells 2Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells 3Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells 4Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 2Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 3Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer 4
... The AB Holter, a ... system, provides sophisticated,ambulatory ECG analysis ... Windows environment.,Designed to use Windows ... the system allows,the option of ...
Olive Shaped Tip Cannula With Straight Shaft; in stainless steel....
... Designed to meet the ... of cardiology practices. The ... attenuation correction accessory features ... array that increases the ...
Sharp diamond shaped double blade in stainless steel....
Medicine Products: